-
Cyclosporin A (B1922): Practical Workflow Guide
2026-10-01
This guide explains how to use Cyclosporin A (B1922) in solvent-based cellular and biochemical workflows involving cyclophilin inhibition, calcineurin-NFAT signaling, immune suppression, and apoptosis modulation. It is not suitable for aqueous-only protocols without a validated formulation, and product-listed conditions should be treated as starting points rather than universal assay settings.
-
Meropenem Assay Design for Resistance Research
2026-10-01
Meropenem assay design should separate target engagement, exposure, and resistance rather than treating susceptibility as a single endpoint. This guide translates β-lactam pharmacodynamics into practical workflows for septicemia treatment research, Gram-negative infection models, and carbapenem-resistant bacterial infections.
-
Sodium Dicloxacillin Monohydrate for MSSA Research
2026-09-30
Sodium dicloxacillin monohydrate is a narrow-spectrum β-lactam research compound for penicillin-binding protein studies involving methicillin-sensitive Staphylococcus aureus. Reported potency depends on strain, cellular compartment, and pH, so experimental interpretation requires explicit assay conditions and validated controls.
-
Ceftolozane-Tazobactam in Nosocomial Pneumonia
2026-09-30
The reference article explains how ceftolozane-tazobactam combines structural protection from AmpC hydrolysis with focused antipseudomonal activity and time-dependent pharmacology. Its synthesis of susceptibility, PK/PD, and ASPECT-NP evidence supports the combination as an important option for nosocomial pneumonia while also clarifying the limits of extrapolating in vitro activity to clinical treatment.
-
EMD638683: Practical SGK1 Inhibitor Workflows
2026-09-29
EMD638683 supports mechanism-focused studies spanning endothelial stiffness, NDRG1 target engagement, tumor-cell signaling, and hypertension models. This guide translates published SGK1 biology into practical dosing, controls, readouts, formulation choices, and troubleshooting steps.
-
Clarithromycin as a CYP3A Translational Probe
2026-09-29
Clarithromycin is more than a macrolide antibiotic in translational research: it is a practical CYP3A inhibitor for testing how enzyme-mediated metabolism shapes exposure, efficacy, and safety. This article connects mechanistic assay design with statin metabolism interaction, cardiovascular drug interaction, pharmacokinetic studies, and the interpretation of CYP3A-independent agents such as dabigatran.
-
Aztreonam as a Precision Probe in Gram-Negative Research
2026-09-28
Aztreonam is a monocyclic β-lactam antibiotic that can serve as a defined cell-wall perturbation in Gram-negative research. This article connects practical compound handling with a resistance-surveillance study, clarifying what its findings can—and cannot—tell researchers about Aztreonam assays.
-
3-Aminobenzamide: PARP-IN-1 Research Workflows
2026-09-27
Learn how to use 3-Aminobenzamide (PARP-IN-1) to probe PARP activity in oxidative-stress, endothelial, and renal models, with practical dose-ranging and troubleshooting guidance. A coronavirus study offers a useful host–virus hypothesis to test, but does not establish 3-Aminobenzamide as an antiviral treatment or validate it in that model.
-
5-hme-dCTP for Plant Epigenetic Assays
2026-09-26
Use 5-hme-dCTP to test polymerase incorporation and build hydroxymethylated DNA controls—not as a stand-alone readout of endogenous 5hmC. A control-led workflow helps researchers interpret low-abundance, stress-responsive signals in plant epigenetic DNA modification research.
-
Canine Staphylococci: Mupirocin and Novobiocin
2026-09-26
This study compared in vitro mupirocin and novobiocin susceptibility in meticillin-susceptible and meticillin-resistant staphylococci isolated from healthy dogs and dogs with superficial pyoderma. Mupirocin susceptibility was broadly similar across groups, while novobiocin susceptibility varied in the observed isolates; the findings support isolate-based testing but do not establish clinical treatment outcomes.
-
Methicillin Sodium Salt for MSSA Research
2026-09-25
Use Methicillin sodium salt as a defined MSSA susceptibility comparator—not as a way to suppress MRSA extracellular-vesicle signaling. This guide connects MIC testing and bacterial controls with an OSCC vesicle workflow, while separating established product parameters from exploratory assay suggestions.
-
Amplex Red Assays: Workflow, Uses & Controls
2026-09-25
Amplex Red turns hydrogen peroxide into a measurable resorufin signal for sensitive enzyme and redox assays. A key caveat: carboxylesterases can also generate resorufin, so robust workflows need sample-specific background controls—especially for liver and mitochondrial preparations.
-
Hexetidine: What Biofilm Maturity Changes
2026-09-24
Hexetidine (NSC-17764) is known for broad antimicrobial activity, but its behavior changes when bacteria attach to a medical-device surface and develop into a biofilm. This evidence-led analysis examines a PVC endotracheal-tube study to show why biofilm age, growth state, and model choice matter when interpreting antimicrobial results.
-
Dhcr7-Edited Grass Carp Show GCRV Resistance
2026-09-24
A 2026 study used CRISPR/Cas9 to disrupt dhcr7 in grass carp and found that edited fish had higher survival after GCRV-II challenge, stronger antiviral responses, lower viral loads, and less hepatopancreas damage. The results establish Dhcr7 as an in vivo candidate for disease-resistance breeding, while leaving questions about mechanism, long-term effects, and performance across strains and farming conditions.
-
TRPM3 Modulation by Neurosteroids and Primidone
2026-09-23
Yin and colleagues combine cryo-EM, electrophysiology, molecular dynamics, and mass spectrometry to define how pregnenolone sulfate, CIM0216, and primidone regulate the TRPM3 ion channel. The study connects ligand-binding sites with channel gating and disease-associated gain-of-function mutations, providing a structural framework for pain and neurodevelopmental disorder research.